Jazz Pharmaceuticals plc — Director's Dealing 2021

Oct 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2021-10-04

Reporting Person: COZADD BRUCE C (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-04	Ordinary Shares	M	9700	$46.83	Acquired	318990	Direct
2021-10-04	Ordinary Shares	S	6598	$129.8731	Disposed	312392	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-04	Non-Qualified Stock Option (right to buy)	$46.83	M	9700	Disposed	2022-08-08	Ordinary Shares (9700)	Direct

Footnotes

F1: Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options.

F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3: This Non-qualified stock option is part of an option granted on August 9, 2012. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016.